P. Deegan et al., Association between low-density lipoprotein composition and its metabolismin non-insulin-dependent diabetes mellitus, METABOLISM, 48(1), 1999, pp. 118-124
Atheroma is related to low-density lipoprotein (LDL) composition. LDL in di
abetic patients-a group with increased risk of severe atheroma-has been sho
wn by our group and others to have various compositional alterations that a
re potentially atherogenic. Little is known about the relationship between
LDL turnover and composition. This study examined the relationship between
LDL composition and turnover in non-insulin-dependent diabetes mellitus (NI
DDM) patients. Twenty-two NIDDM patients with a mean plasma cholesterol of
6.6 +/- 1.5 mmol/L were studied. Twelve subjects were hypercholesterolemic
(mean cholesterol, 7.7 +/- 0.8 mmol/L), and eight of these agreed to be stu
died a second time after 4 weeks of treatment with simvastatin. LDL was iso
lated by density gradient ultracentrifugation, iodinated, and reinjected in
to the patient. LDL turnover was determined by measuring the clearance of [
I-125]-LDL from plasma over a 10-day period. The LDL residence time, determ
ined using a biexponential model, correlated negatively with the body mass
index (BMI) (r = -.73, P <.001) and serum triglycerides (r -.57, P <.01). T
here was a significant inverse correlation between LDL residence time and t
he LDL esterified to free cholesterol ratio in hypercholesterolemic subject
s (r = -.94, P <.001). There was a significant inverse relationship between
LDL residence time and both hemoglobin A(1c) (HbA(1c),) and fasting blood
glucose in these subjects before treatment (P <.005). After simvastatin the
rapy, the relationships were no longer significant. Simvastatin treatment w
as associated with a shorter LDL residence time (P <.01) and a decrease in
LDL glycation (P <.001) with virtually no change in diabetic control (HbA(1
c) 6.0% +/- 3.1% v 6.3% +/- 3.3%, NS). This study suggests that a decrease
in residence time by upregulation of the LDL receptor with simvastatin alte
rs LDL composition in a way that is likely to render the particle less athe
rogenic. Copyright (C) 1999 by W.B. Saunders Company.